SpectraCure AB (publ)
SSE:SPEC.ST
2.6 (SEK) • At close February 20, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | SpectraCure AB (publ) |
Symbool | SPEC.ST |
Munteenheid | SEK |
Prijs | 2.605 |
Beurswaarde | 253,027,818 |
Dividendpercentage | 0% |
52-weken bereik | 2.225 - 6.6 |
Industrie | Medical Devices |
Sector | Healthcare |
CEO | Dr. Masoud Khayyami Ph.D. |
Website | https://www.spectracure.com |
An error occurred while fetching data.
Over SpectraCure AB (publ)
SpectraCure AB (publ) focuses on cancer treatment utilizing laser light sources and photo reactive drugs. It develops IDOSE software with interstitial photodynamic therapy system, which is in Phase II clinical trial for the treatment of solid tumors. The company was founded in 2003 and is based in Lund, Sweden.
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (SEK)
Cijfers zijn in miljoenen (SEK)